A case study of a patient with refractory, progressive pancreatic cancer who benefited from a single infusion of a novel T-cell receptor (TCR) transduction therapy holds promise ― but only for the ...

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...

Piezo4Spine is a European project that aims to develop a novel therapy to repair the injured spinal cord, a pathology for ...

A review of the novel sustained release approach with bimatoprost implants and how this is affecting glaucoma management. Neil Minkoff, MD: Where in the treatment protocols, or in your treatment ...

Please provide your email address to receive an email when new articles are posted on . Researchers reported median OS of 14.2 months among patients with preexisting antibodies to HSV1 virus. The ...

ADEL-Y01, a monoclonal antibody targeting tau protein, is in Phase I trials for Alzheimer's disease, developed by ADEL and ...

An experimental neural cell therapy is safe and led to greater than 90% reduction in seizures in two patients with drug-resistant mesial temporal lobe epilepsy (MTLE) in the first-in-human test of the ...

A new preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR) following a ...

Rafael Kramann, MD, PhD, FASN, FERA, embraced the field of nephrology early in his career for the opportunity to take on ...

Scientists have developed a bio-functional thermogel, a type of synthetic polymer, to prevent retinal scarring caused by failed retinal detachment repair surgery. Proliferative vitreoretinopathy (PVR) ...